dr greger glp-1 Michael GLP-1 Drugs for Weight Loss
Description
Half of the patients (50%) treated with colesevelam (N = 26) experienced 25% reduction in the number of bowel movements per day, whereas a significantly greater proportion (77%) of patients treated with liraglutide (N = 26) met the primary endpoint (20)
Sheila Burdicks Post Are you on a GLP-1 journey to better health
Randomized, placebo-controlled study of liraglutide 1.8 mg in 135 children ages 1016 with type 2 diabetes that found that treatment with liraglutide resulted in a 1.3% reduction in HbA1c compared with placebo
doi: 10.1111/jcmm.17441 111 HammadMMMohammadAAlam-EldinNMadhuDAl-MullaFAbu-FarhaMet al
